• scPharmaceuticals to Participate in the 12th Annual LifeSci Partners Corporate Access Event

    Source: Nasdaq GlobeNewswire / 14 Dec 2022 07:00:01   America/Chicago

    BURLINGTON, Mass., Dec. 14, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, President & Chief Executive Officer, is scheduled to participate in the 12th Annual LifeSci Partners Corporate Access Event, on Monday, January 9 and Tuesday, January 10, 2023, in San Francisco. Learn more about the event and schedule an in-person meeting with the scPharmaceuticals management here.

    About scPharmaceuticals
    scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.

    Katherine Taudvin
    scPharmaceuticals Inc., 781-301-6706
    ktaudvin@scpharma.com

    Investors:
    Hans Vitzthum
    LifeSci Advisors, 617-430-7578
    hans@lifesciadvisors.com 


    Primary Logo

Share on,